U.S. markets close in 2 hours 40 minutes
  • S&P 500

    3,862.61
    -7.68 (-0.20%)
     
  • Dow 30

    31,556.38
    +164.86 (+0.53%)
     
  • Nasdaq

    13,193.79
    -164.99 (-1.24%)
     
  • Russell 2000

    2,240.39
    +8.88 (+0.40%)
     
  • Crude Oil

    61.83
    +2.08 (+3.48%)
     
  • Gold

    1,716.10
    -17.50 (-1.01%)
     
  • Silver

    26.35
    -0.52 (-1.95%)
     
  • EUR/USD

    1.2080
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • GBP/USD

    1.3973
    +0.0017 (+0.12%)
     
  • USD/JPY

    106.9300
    +0.2200 (+0.21%)
     
  • BTC-USD

    51,510.39
    +3,974.64 (+8.36%)
     
  • CMC Crypto 200

    1,031.41
    +43.31 (+4.38%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Inovio Pharmaceuticals's Earnings: A Preview

  • Oops!
    Something went wrong.
    Please try again later.
Benzinga Insights
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Inovio Pharmaceuticals (NASDAQ: INO) releases its next round of earnings this Monday, November 09. Get the latest predictions in Benzinga's essential guide to the company's Q3 earnings report.

Net Income, Earnings, And Earnings Per Share

Earnings and EPS are useful metrics of profitability. Total earnings also known as net income is equal to total revenue minus total expenses. Dividing net income by the total number of shares outstanding yields EPS.

Earnings And Revenue

Based on Inovio Pharmaceuticals management projections, analysts predict EPS of $0.19 on revenue of $3.05 million. In the same quarter last year, Inovio Pharmaceuticals posted EPS of $0.25 on sales of $866.86 thousand.

What Are Analyst Estimates And Earnings Surprises, And Why Do They Matter?

Wall Street analysts who study this company will publish analyst estimates of revenue and EPS. The averages of all analyst EPS and revenue estimates are called the "consensus estimates"; these consensus estimates can have a significant effect on a company's performance during an earnings release. When a company posts earnings or revenue above or below a consensus estimate, it has posted an "earnings surprise", which can really move a stock depending on the difference between actual and estimated values.

View more earnings on INO

If the company were to post earnings in line with the consensus estimate when it reports Monday, EPS would be up 24.0%. Revenue would be up 251.84% on a year-over-year basis. Inovio Pharmaceuticals's reported EPS has stacked up against analyst estimates in the past like this:

EPS Estimate

-0.17

-0.22

-0.24

-0.26

EPS Actual

-0.20

-0.26

-0.38

-0.25

Revenue Estimate

2.61 M

1.91 M

2.32 M

3.93 M

Revenue Actual

267.19 K

1.33 M

279.00 K

866.86 K

Stock Performance

Shares of Inovio Pharmaceuticals were trading at $10.8 as of November 05. Over the last 52-week period, shares are up 327.76%. Given that these returns are generally positive, long-term shareholders can be satisfied going into this earnings release.

Do not be surprised to see the stock move on comments made during its conference call. Inovio Pharmaceuticals is scheduled to hold the call at 16:30:00 ET and can be accessed here.

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.